Vazegepant HCl

CAS No. 1414976-20-7

Vazegepant HCl( —— )

Catalog No. M22411 CAS No. 1414976-20-7

Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 330 In Stock
5MG 227 In Stock
10MG 334 In Stock
25MG 565 In Stock
50MG 789 In Stock
100MG 1088 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Vazegepant HCl
  • Note
    Research use only, not for human use.
  • Brief Description
    Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
  • Description
    Vazegepant is the first intranasal gepant for the acute treatment of migraine and has announced a positive phase II/III study.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1414976-20-7
  • Formula Weight
    675.3
  • Molecular Formula
    C36H47ClN8O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Cl.CN1CCC(CC1)N1CCN(CC1)C(=O)[C@@H](Cc1cc(C)c2[nH]ncc2c1)NC(=O)N1CCC(CC1)c1cc2ccccc2[nH]c1=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Moreno-Ajona D , Abigail Pérez-Rodríguez, Goadsby P J . Gepants, calcitonin-gene-related peptide receptor antagonists: what could be their role in migraine treatment?[J]. Current Opinion in Neurology, 2020, 33(3):1.
molnova catalog
related products
  • 8,9-epoxy-3,10-diiso...

    10-Isobutyryloxy-8,9-epoxythymol isobutyrate is a major constituent of Inula helenium and Inula royleana root cultures. 10-Isobutyryloxy-8,9-epoxythymol isobutyrate shows moderate antimicrobial activity against Staphylococcus aureus FDA 209 P, Staphylococcus aureus, Enterococcus faecalis,Candida albicans and Pseudomonas aeruginosa with MICs of 50, 250, 250, 250, and 1000 μg/mL, respectively.

  • Atrial natriuretic f...

    Atrial Natriuretic Peptide (ANP) (1-28),rat (TFA) is the main circulating forms of Atrial Natriuretic Peptide (ANP) in rats, which strongly inhibit the secretion of Ang II - stimulated endothelin-1.

  • Xanthosine

    Xanthosine is produced by guanine-free mutants of bacteria e. g. Bacillus subtilis, Aerobacter aerogenes.